In the BioHarmony Drug Report Database

"Preview" Icon

Modafinil

Provigil (modafinil) is a small molecule pharmaceutical. Modafinil was first approved as Provigil on 1998-12-24. It is used to treat attention deficit disorder with hyperactivity, fatigue, narcolepsy, and obstructive sleep apnea in the USA. It is known to target sodium-dependent dopamine transporter. Provigil’s patent is valid until 2023-11-29 (FDA).

 

Trade Name

 

Provigil
 

Common Name

 

modafinil
 

ChEMBL ID

 

CHEMBL1373
 

Indication

 

attention deficit disorder with hyperactivity, fatigue, narcolepsy, obstructive sleep apnea
 

Drug Class

 

Image (chem structure or protein)

Modafinil structure rendering